Has Gabriel Eduardo Arias Berrios, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,572 in general payments to Gabriel Eduardo Arias Berrios, MD across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gabriel Eduardo Arias Berrios, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gabriel Eduardo Arias Berrios, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gabriel Eduardo Arias Berrios, MD

Dermatology · Bayamon, PRNPI 1053869586

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.5% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 30.3% of the total. Reporting peaked in 2021 at $1,352 and has fallen 56.7% since, to $586 in 2025.

$5,572in general payments, 2019–2025

Across 172 payments — averaging $32.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Sanofi$1K
Johnson & Johnson$690
E.r. Squibb & Sons, L.L.C.$464
Eli Lilly Export S.A. Puerto Rico Branch$340
PBG Puerto Rico LLC$260
plus $1K from 9 others

What the payments were for

Food & beverage$5,15392%
Education$4198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	56	$1,690
Sanofi	33	$1,064
Johnson & Johnson(2 entities)	25	$690
E.r. Squibb & Sons, L.L.C.	11	$464
Eli Lilly Export S.A. Puerto Rico Branch	15	$340
PBG Puerto Rico LLC	12	$260
Sanofi-aventis U.S. LLC	3	$232
Sun Pharmaceutical Industries Inc.	2	$219
Genentech USA, Inc.	5	$203
LEO Pharma Inc.	2	$145
Janssen Scientific Affairs, LLC	1	$120
Amgen	4	$80
Kyowa Kirin, Inc.	1	$28
Verity Pharmaceuticals Inc.	1	$23
Pfizer	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Skyrizi$491
DUPIXENT$490
Sotyktu$231
XOLAIR$125
Rinvoq$125
Humira$125
ADBRY$120
Tremfya$120
ODOMZO$119

How this compares

$5,572 in reported general payments places this provider in the 80th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024

$7,400

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	749	$17,953
Betamethasone Valerate	345	$14,899
Mometasone Furoate	232	$6,138
Tacrolimus	41	$5,812
Metronidazole	89	$5,120
Triamcinolone Acetonide	443	$4,637
Ciclopirox	102	$2,902
Clindamycin Phosphate	56	$1,685
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	60	$1,599
Clobetasol Propionate	42	$1,559
Fluocinolone AcetonideFluocinolone/Shower Cap	19	$1,530
Hydrocortisone	178	$1,459
Permethrin	21	$1,203
Fluorouracil	15	$1,152
Minocycline Hcl	37	$1,055

Paid to pharmacies, not to this prescriber.

Other dermatology in Bayamon

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →